Clinical trial
A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire
NCT07054541 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences, Fuwai Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Novel Echocardiography-Guided Strategy for Percutateous Closure of Atrial Septal Defect Assisted by PannaWire
- Lead sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- March 14, 2026
- Completion date
- October 31, 2027
- Enrollment
- 666 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial septal defect (asd)